Faircraft and BSF Enterprise drive innovation in sustainable lab-grown leather

Faircraft, a French biotech start-up, has successfully raised $15.8 million to advance its lab-grown leather production. This funding, backed by notable investors such as Kindred Ventures, Cap Horn, and Alliance for Impact, is set to scale the company’s operations to meet growing demand for sustainable materials. CEO Haïkel Balti highlighted the revolutionary potential of lab-grown leather, enabling the creation of eco-friendly products while providing new opportunities for artisans and designers.

The field of lab-grown leather continues to grow, with 3D Bio-Tissues, supported by BSF Enterprise, achieving a significant breakthrough. At the Future Fabrics Expo in London, the start-up unveiled its innovative leather sample, created from ethically sourced horse cells. This material mirrors the structural and genetic properties of traditional leather but is cultivated in a lab over six weeks without plastics or cellulose. Its flexibility in tanning methods, whether conventional or eco-conscious, adds to its versatility and appeal.

What sets 3D Bio-Tissues apart is its patented City-mix cell culture supplement, which is serum-free and animal-free. This unique formula accelerates tissue growth and reduces production costs, resulting in leather entirely derived from animal tissue without causing harm. Additionally, the process addresses the environmental concerns of conventional leather tanning. Applications for this sustainable leather extend across industries, including fashion, automotive, furniture, and accessories.

Balti emphasised that lab-grown leather is not just an ethical solution but a technological innovation that opens up creative possibilities for designers while significantly reducing environmental impact. Combining the durability and beauty of traditional leather with sustainability, it sets a new standard for responsible material innovation.

With Faircraft and BSF Enterprise at the forefront, lab-grown leather is reshaping the future of materials. These advancements highlight a successful balance between cutting-edge technology and environmental stewardship, offering sustainable alternatives across a variety of industries.

BSF Enterprise plc (LON:BSFA), the owner of pioneering UK-based clinical and cellular agriculture company 3D Bio-Tissues, is unlocking the next generation of biotech solutions. It is achieving this through an acquisition-led growth strategy to drive the development of lab-grown tissues.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
BSF Enterprise plc

More articles like this

BSF Enterprise plc

The potential of cultivated meat in advancing sustainability

As COP 29 unfolds, there is growing hope that cultivated meat may finally gain the essential financial and regulatory support needed to achieve scalability and commercial success. Che Connon, managing director of BSF Enterprise and CEO

BSF Enterprise plc

Breakthrough in corneal regenerative therapies

Kerato’s innovative “biosynthetic cornea” provides a promising alternative to traditional donor corneal transplants. Designed for one-time use, this injectable device is administered single-handedly. It forms a self-sealing gel in the eye, which reduces inflammation, promotes tissue

BSF Enterprise plc

BSF Enterprise achieves Global Certification for Quality Management

BSF Enterprise, along with its subsidiaries, has recently achieved ISO 9001 certification, a globally recognised standard for quality management systems. This accomplishment signifies a strong commitment to quality across all areas of the company, reinforcing its

BSF Enterprise plc

A new standard in cell culture care with CytoBoost

CytoBoost is a new, premium approach to cell culture, offering laboratories a way to enhance the health and performance of their cells. With this innovative product, you can think of CytoBoost as a dedicated solution designed

BSF Enterprise plc

UK’s opportunity to lead in cell-grown meat production

Europe’s approach to the agri-tech revolution is increasingly viewed as outdated, with its regulations often criticised as overly protectionist and wary of technological advancements. The continent’s approach to cell-grown meat production mirrors this attitude, with the

BSF Enterprise plc

Advances in corneal transplants in ophthalmology

The aging global population is driving a rise in vision impairment, which in turn affects physical, cognitive, and mental health. Among the most commonly transplanted human tissues worldwide are corneas, with approximately 185,000 procedures performed annually.

BSF Enterprise plc

UK biotech company expands production of lab-grown leather

A UK-based biotech company recently achieved a significant milestone by producing a larger size of cultivated skin tissue at its laboratory in Newcastle. The company, Lab-Grown Leather (LGL), formerly known as 3D Bio-Tissues, is owned by

BSF Enterprise plc

Is artificial leather a viable alternative?

Artificial leather is often marketed as a more sustainable option compared to traditional leather, yet questions remain about whether it truly delivers on this promise. Environmental concerns still surround the production of artificial leather, particularly the

BSF Enterprise plc

Cultivated meat and its potential

Cultivated meat, also known as cultured meat, is real animal meat produced by cultivating animal cells directly, removing the need for traditional animal farming. This meat is composed of the same cell types as conventional meat,

BSF Enterprise plc

BSF Enterprise making strong progress across portfolio of companies

BSF Enterprise PLC (LON:BSFA), the parent to a portfolio of innovative subsidiary companies developing cell-based tissue engineering solutions to deliver sustainable outcomes across a variety of sectors, has provided the following portfolio update. ●     Lab Grown Leather (LGL): Revolutionising

BSF Enterprise plc

Lab-Grown Leather expands sustainable leather production capacity

Lab-Grown Leather Ltd (LGL) has made a significant step forward by increasing its production capacity for lab-grown leather. This development highlights the potential of their technology to revolutionise the leather industry, providing a sustainable and ethical